POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis. - Menzies AM; Long GV; Kohn A; Tawbi H; Weber J; Flaherty K; McArthur GA; Ascierto PA; Pfluger Y; Lewis K; Tsai KK; Hamid O; et al. (Neuro-oncology advances, 2024)